Page last updated: 2024-09-03

toosendanin and Carcinoma, Anaplastic

toosendanin has been researched along with Carcinoma, Anaplastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, XY; Hou, LD; Huang, YX; Liu, H; Wang, G; Zhang, J; Zhang, R; Zhu, JS	1

Other Studies

1 other study(ies) available for toosendanin and Carcinoma, Anaplastic

Article	Year
Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC‑7901 cells partly via miR‑200a‑mediated downregulation of β-catenin pathway. International journal of oncology, 2017, Volume: 51, Issue:5 Topics: Animals; Apoptosis; beta Catenin; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Mice; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Stomach Neoplasms; Wnt Signaling Pathway; Xenograft Model Antitumor Assays	2017

Article

Year

Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC‑7901 cells partly via miR‑200a‑mediated downregulation of β-catenin pathway.

International journal of oncology, 2017, Volume: 51, Issue:5

Topics: Animals; Apoptosis; beta Catenin; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drugs, Chinese Herbal; Epithelial-Mesenchymal Transition; Gene Expression Regulation, Neoplastic; Humans; Mice; MicroRNAs; Neoplasm Invasiveness; Neoplasm Metastasis; Stomach Neoplasms; Wnt Signaling Pathway; Xenograft Model Antitumor Assays

2017